How Bad Are A.I. Delusions? We Asked People Treating Them
David S. Williams III David S. Williams III

How Bad Are A.I. Delusions? We Asked People Treating Them

Dozens of doctors and therapists said chatbots had led their patients to psychosis, isolation and unhealthy habits. Julia Sheffield, a psychologist at Vanderbilt University Medical Center in Nashville, is navigating how to treat problems caused or exacerbated by A.I. chatbots.

Read More
Breyer Capital 2026 Healthcare and Life Sciences Predictions
David S. Williams III David S. Williams III

Breyer Capital 2026 Healthcare and Life Sciences Predictions

In 2026, capital, talent, and economics will continue to reorganize around these axes: computationprecision, and prevention. The predictions that follow mark inflection points where technological maturity meets market readiness, and where we anticipate substantial activity this year.

Read More
Follow OVERLAB on Instagram
David S. Williams III David S. Williams III

Follow OVERLAB on Instagram

Follow us on our new Instagram account featuring founder stories, industry insights, and investor secrets not found anywhere else.

Read More
What’s next for AI in 2026
David S. Williams III David S. Williams III

What’s next for AI in 2026

In an industry in constant flux, sticking your neck out to predict what’s coming next may seem reckless. (AI bubble? What AI bubble?) But for the last few years we’ve done just that—and we’re doing it again. 

Read More
2026 Outlook: Setting the standard for health AI programs
David S. Williams III David S. Williams III

2026 Outlook: Setting the standard for health AI programs

In the back half of 2025,  a slew of organizations announced forthcoming artificial intelligence certification programs that would offer providers and developers the opportunity to align their AI practices with technical and ethical standards.

Read More